Om

Neurothera Labs Inc. is a clinical-stage pharmaceutical company focused on developing cannabinoid-based therapies for neurological and neurodevelopmental disorders. Neurothera Labs Inc. currently advances drug development programs built around THC and non-psychoactive CBD, with candidate treatments addressing conditions such as Tourette syndrome, Alzheimer’s disease, agitation, autism spectrum disorder, and status epilepticus. The company operates in the pharmaceuticals and biotechnology sector from Vancouver, Canada, and its work centers on translating research into therapeutic products aimed at complex central nervous system disorders. Neurothera Labs Inc. plays a specialized role in the market by targeting underserved treatment areas where novel pharmaceutical approaches may be clinically relevant.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I NEUROTHERA LABS MED ENDAVU: Køb NeuroThera Labs ($NTLX) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i NeuroThera Labs, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.